Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainNeurexophilin

NXPE4 NXPH1 NXPH2

3.10e-0581563PF06312
DomainNXPH/NXPE

NXPE4 NXPH1 NXPH2

3.10e-0581563IPR026845
DomainDUF4599

SPATA31A3 SPATA31C2 SPATA31A6

1.19e-04121563PF15371
DomainDUF4599

SPATA31A3 SPATA31C2 SPATA31A6

1.19e-04121563IPR027970
DomainPRPP_SYNTHASE

PRPS1L1 PRPS1

2.07e-0431562PS00114
DomainPRib_PP_synth_CS

PRPS1L1 PRPS1

2.07e-0431562IPR000842
Pubmed

Infection with Syphacia obvelata (pinworm) induces protective Th2 immune responses and influences ovalbumin-induced allergic reactions.

IL12B IFNGR1 IL4

9.49e-075160316988272
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

USP34 TRAF2 FAT3 SMARCAD1 BCR SP110 FAM53C ADCY9 TFDP1 CEP170 GLI3 ZNF589 ASPM WDFY3 RAPGEF2 DNA2 MGA ZNF574 AURKB

1.02e-0611161601931753913
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

AMD1 MCPH1 RHBDF2 ZNF189 BARD1 LHPP BCR TTF1 DNAH1 MIPOL1 CEP170 KMT2C THEM4 TBC1D4 ZNF33A TLE5 ZNF589 BOD1L1 FGF13 ANKRD12 RAPGEF2 BAIAP3

1.43e-0614891602228611215
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A3 SPATA31A6 SPATA31A1

1.89e-066160320850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A3 SPATA31A6 SPATA31A1

1.89e-066160325930072
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

USP34 TRAF2 CNST EIF4A3 CEP57L1 ZNF189 SMARCAD1 CMYA5 FAM53C RYR3 MIPOL1 CEP350 HEATR6 DST PTPRK WDFY3 RAPGEF2 ZMYM5 ZNF292

7.83e-0612851601935914814
Pubmed

Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis.

MCPH1 PECAM1 AURKB

7.87e-069160338605277
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

USP34 ADCY9 TBC1D4 PACS2 MGA ZNF292

9.54e-0610516069628581
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DAB2IP TPR BCR CEP170 DST AKAP9 ATF7IP TAX1BP1 MFN2 ELAVL3 KIF4B KIF5B WDFY3 RAPGEF2 UBASH3B MGA

1.04e-059631601628671696
Pubmed

Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.

IL12B KLRB1 IL4

1.12e-0510160318451996
Pubmed

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

IL12B IFNGR1 IL4

1.53e-0511160316954498
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

USP34 KBTBD2 ADCY9 CEP350 UBXN4 ARFRP1 DST ATF7IP GLI3 RAPGEF2 PIH1D1 MGA NOL8 PRPS1

1.57e-057771601435844135
Pubmed

A human MAP kinase interactome.

TPR FAM53C CEP350 KMT2C CSE1L DST TLE5 ATF7IP KIF5B RAPGEF2 MGA

1.70e-054861601120936779
Pubmed

Analysis of pituitary gonadotropin concentration in blood serum and immunolocalization and immunoexpression of follicle stimulating hormone and luteinising hormone receptors in ovaries of postmenopausal women.

LHCGR FSHR

2.10e-052160222207559
Pubmed

Cutting edge: polarized Th cell response induction by transferred antigen-pulsed dendritic cells is dependent on IL-4 or IL-12 production by recipient cells.

IL12B IL4

2.10e-052160211907061
Pubmed

Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.

CYP24A1 CSE1L

2.10e-052160232270348
Pubmed

The detection of tumor location and lymph node metastasis by aberrant NXPH1 and NXPH2 expressions in pancreatic ductal adenocarcinomas.

NXPH1 NXPH2

2.10e-052160227817196
Pubmed

Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity.

IL12B IL4

2.10e-052160211960636
Pubmed

Association of human follitropin (FSH) receptor with splicing variant of human lutropin/choriogonadotropin receptor negatively controls the expression of human FSH receptor.

LHCGR FSHR

2.10e-052160215890674
Pubmed

The effect of splice variant of the human luteinizing hormone (LH) receptor on the expression of gonadotropin receptor.

LHCGR FSHR

2.10e-052160217092637
Pubmed

The Luteinizing Hormone Receptor Knockout Mouse as a Tool to Probe the In Vivo Actions of Gonadotropic Hormones/Receptors in Females.

LHCGR FSHR

2.10e-052160233605422
Pubmed

Associations of FSHR and LHCGR gene variants with ovarian reserve and clinical pregnancy rates.

LHCGR FSHR

2.10e-052160234391684
Pubmed

Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism.

LHCGR FSHR

2.10e-052160223884663
Pubmed

Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.

LHCGR FSHR

2.10e-052160225649397
Pubmed

Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.

IFNGR1 IL4

2.10e-05216029382883
Pubmed

IL-4-deficient Balb/c mice resist infection with Leishmania major.

IFNGR1 IL4

2.10e-05216029064329
Pubmed

Primary microcephaly: microcephalin and ASPM determine the size of the human brain.

MCPH1 ASPM

2.10e-052160212571366
Pubmed

Tone and genes: New cross-linguistic data and methods support the weak negative effect of the "derived" allele of ASPM on tone, but not of Microcephalin.

MCPH1 ASPM

2.10e-052160234191836
Pubmed

Constitutively active follicle-stimulating hormone receptor enables androgen-independent spermatogenesis.

LHCGR FSHR

2.10e-052160229584617
Pubmed

Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations.

LHCGR FSHR

2.10e-052160217609213
Pubmed

Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.

IL12B IFNGR1

2.10e-052160212702051
Pubmed

Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12.

IL12B IFNGR1

2.10e-05216028752933
Pubmed

The murine luteinizing hormone and follicle-stimulating hormone receptor genes: transcription initiation sites, putative promoter sequences and promoter activity.

LHCGR FSHR

2.10e-05216021459341
Pubmed

Investigation of MCPH1 G37995C and ASPM A44871G polymorphisms and brain size in a healthy cohort.

MCPH1 ASPM

2.10e-052160217566767
Pubmed

Targeting gonadotropin receptor genes: reproductive biology, aging, and related health implications.

LHCGR FSHR

2.10e-052160216034175
Pubmed

Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion injury.

IL12B IL4

2.10e-052160216741373
Pubmed

No evidence that polymorphisms of brain regulator genes Microcephalin and ASPM are associated with general mental ability, head circumference or altruism.

MCPH1 ASPM

2.10e-052160217251122
Pubmed

Infertility and ovarian follicle reserve depletion are associated with dysregulation of the FSH and LH receptor density in human antral follicles.

LHCGR FSHR

2.10e-052160228188844
Pubmed

A common SNP of MCPH1 is associated with cranial volume variation in Chinese population.

MCPH1 ASPM

2.10e-052160218204051
Pubmed

Mechanisms of gonadotropin desensitization.

LHCGR FSHR

2.10e-052160211988313
Pubmed

Deregulation of microcephalin and ASPM expression are correlated with epithelial ovarian cancer progression.

MCPH1 ASPM

2.10e-052160224830737
Pubmed

Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry.

LHCGR FSHR

2.10e-052160223118426
Pubmed

Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.

KLRB1 IL4

2.10e-05216029130646
Pubmed

 Effects of interleukin-4 and interleukin-12B gene polymorphisms on hepatitis B virus vaccination.

IL12B IL4

2.10e-052160228051794
Pubmed

Normal induction of oral tolerance in the absence of a functional IL-12-dependent IFN-gamma signaling pathway.

IL12B IFNGR1

2.10e-052160210528171
Pubmed

Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum.

IL12B IL4

2.10e-052160223527200
Pubmed

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype.

LHCGR FSHR

2.10e-052160233374698
Pubmed

IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection.

IFNGR1 IL4

2.10e-05216029759875
Pubmed

Increased interleukin 4 (IL-4) receptor expression and IL-4-induced decrease in IL-12 production by Langerhans cells infected with Leishmania major.

IL12B IL4

2.10e-052160211854255
Pubmed

Normal variants of Microcephalin and ASPM do not account for brain size variability.

MCPH1 ASPM

2.10e-052160216687438
Pubmed

The ongoing adaptive evolution of ASPM and Microcephalin is not explained by increased intelligence.

MCPH1 ASPM

2.10e-052160217220170
Pubmed

The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.

ADCY9 AKAP9

2.10e-052160222778270
Pubmed

Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.

TRAF2 C5

2.10e-052160216953841
Pubmed

Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology.

LHCGR FSHR

2.10e-052160235842313
Pubmed

Heterodimerization between the lutropin and follitropin receptors is associated with an attenuation of hormone-dependent signaling.

LHCGR FSHR

2.10e-052160223825122
Pubmed

FSH and LH receptors are differentially expressed in cumulus cells surrounding developmentally competent and incompetent mouse fully grown antral oocytes.

LHCGR FSHR

2.10e-052160224476692
Pubmed

Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium.

LHCGR FSHR

2.10e-052160229974367
Pubmed

Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.

LHCGR FSHR

2.10e-052160226769719
Pubmed

Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.

IL12B IFNGR1 IL4

3.35e-0514160317152005
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

ATP5PB UIMC1 MAP9 PHACTR2 CLTCL1 WDR33 EIF4A3 HMGCL PRPS1L1 MIPOL1 UBXN4 DST KIAA0825 ASPM PKHD1 BOD1L1 KIF5B ZNF292 PRPS1

3.83e-0514421601935575683
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

CCDC170 DNAH3 MCPH1 MYO7A TBC1D2 MYOM3 PARP14 MIPOL1 KMT2C TBC1D4 DST PKHD1 BOD1L1

3.91e-057361601329676528
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

ATP5PB AMD1 UIMC1 WDR33 BARD1 CEP350 CEP170 DST TAX1BP1 SGO2 KIF5B AURKB

4.77e-056451601225281560
Pubmed

DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.

USP34 UIMC1 MCPH1 BARD1 SP110 TRIM22 ETAA1 SGO2 BOD1L1 MGA

5.10e-054531601029656893
Pubmed

Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice.

IL12B KLRB1 IL4

6.20e-051716039175833
Pubmed

IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis.

IL12B IL4

6.29e-05316029933080
Pubmed

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.

RHBDF2 TRIM31

6.29e-053160235217669
Pubmed

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.

IL12B IL4

6.29e-053160212471132
Pubmed

Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.

LHCGR FSHR

6.29e-053160219403562
Pubmed

IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation.

IFNGR1 IL4

6.29e-053160211160342
Pubmed

Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae.

IL12B IFNGR1

6.29e-053160210779789
Pubmed

Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 encoding phosphoribosylpyrophosphate synthetase subunit I and II isoforms.

PRPS1L1 PRPS1

6.29e-05316021314091
Pubmed

IL-4-regulated enteropathy in an intestinal nematode infection.

IFNGR1 IL4

6.29e-05316029754555
Pubmed

Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary.

LHCGR FSHR

6.29e-05316029282997
Pubmed

Mice lacking IL-12 develop polarized Th1 cells during viral infection.

IL12B IFNGR1

6.29e-05316029558103
Pubmed

Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

LHCGR FSHR

6.29e-053160211847099
Pubmed

Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3.

IL12B IL4

6.29e-05316027512032
Pubmed

Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway.

IL12B IFNGR1

6.29e-053160212811839
Pubmed

Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

LHCGR FSHR

6.29e-053160215889138
Pubmed

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

BARD1 AURKB

6.29e-053160222350409
Pubmed

Defective vascular morphogenesis and mid-gestation embryonic death in mice lacking RA-GEF-1.

PECAM1 RAPGEF2

6.29e-053160217826737
Pubmed

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.

LHCGR FSHR

6.29e-053160223951246
Pubmed

Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis.

PECAM1 AFP

6.29e-053160210906784
Pubmed

A novel gene is disrupted at a 14q13 breakpoint of t(2;14) in a patient with mirror-image polydactyly of hands and feet.

MIPOL1 PRPS1

6.29e-053160211954550
Pubmed

Transcriptional changes in dendritic cells underlying allergen specific induced tolerance in a mouse model.

IL12B IFNGR1

6.29e-053160235181694
Pubmed

IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice.

IFNGR1 IL4

6.29e-05316028943375
Pubmed

Genetic heterogeneity in Pakistani microcephaly families revisited.

MCPH1 ASPM

6.29e-053160228004384
Pubmed

The C-terminal region of A-kinase anchor protein 350 (AKAP350A) enables formation of microtubule-nucleation centers and interacts with pericentriolar proteins.

CEP170 AKAP9

6.29e-053160229054927
Pubmed

A genome-wide association study identified a novel genetic loci STON1-GTF2A1L/LHCGR/FSHR for bilaterality of neovascular age-related macular degeneration.

LHCGR FSHR

6.29e-053160228775256
Pubmed

Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.

IL12B IL4

6.29e-053160210982767
Pubmed

Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice.

LHCGR FSHR

6.29e-053160227075695
Pubmed

Disparate Regulatory Mechanisms Control Fat3 and P75NTR Protein Transport through a Conserved Kif5-Interaction Domain.

FAT3 KIF5B

6.29e-053160227788242
Pubmed

Aetiological coding sequence variants in non-syndromic premature ovarian failure: From genetic linkage analysis to next generation sequencing.

LHCGR FSHR

6.29e-053160225960166
Pubmed

LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.

LHCGR FSHR

6.29e-053160225935136
Pubmed

Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-gamma.

IFNGR1 IL4

6.29e-053160219079171
Pubmed

Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions.

LHCGR FSHR

6.29e-05316028747461
Pubmed

Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses.

IL12B IFNGR1

6.29e-053160210457211
Pubmed

IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.

IL12B IL4

6.29e-053160210843696
Pubmed

Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells.

LHCGR FSHR

6.29e-053160217556863
Pubmed

Peripheral blood mononuclear cells from severe asthmatic children release lower amounts of IL-12 and IL-4 after LPS stimulation.

IL12B IL4

6.29e-053160225985710
Pubmed

Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.

KMT2C NR1H4

6.29e-053160221330447
GeneFamilyGlycoprotein hormone receptors

LHCGR FSHR

9.79e-0531042199
GeneFamilyFibronectin type III domain containing

MYOM3 CMYA5 CNTN6 PTPRK PTPRO ATF7IP

3.25e-041601046555
GeneFamilyZinc fingers MYND-type|A-kinase anchoring proteins

MYO7A CMYA5 AKAP9

6.06e-04291043396
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF680 ZNF560 ZNF189 ZIM3 ZNF33A ZNF425 ZNF382 GLI3 ZNF589 ZNF543 ZNF574 ZNF292

8.56e-047181041228
GeneFamilyCD molecules|C-type lectin domain family|Killer cell lectin like receptors

KLRF1 KLRB1

2.08e-03121042621
GeneFamilyC-type lectin domain family

KLRF1 LY75 KLRB1

2.49e-03471043494
GeneFamilyEndogenous ligands|Minor histocompatibility antigens

SP110 TRIM22 LY75

3.15e-03511043870
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

TPR USP34 PHF19 MYO7A PECAM1 RO60 KBTBD2 PARP14 SP110 TRIM22 GLCCI1 CEP350 LIMD2 KMT2C UBXN4 TBC1D4 AKAP9 TLE5 GLG1 ATF7IP BOD1L1 UBASH3B KLRB1 ZMYM5 ZNF292

3.72e-06149215925M40023
CoexpressionBENPORATH_ES_1

AMD1 GAD1 TRIM22 DDIAS CSE1L ZNF589 FGF13 DNA2 KLKB1 AURKB PRPS1

2.14e-0537915911M1871
CoexpressionGSE360_CTRL_VS_L_MAJOR_MAC_DN

PDE1A CNTN6 PRPS1L1 CEP170 FBLN1 AKAP9 PTPRK ELAVL3

2.84e-051971598M5161
CoexpressionGSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP

CCDC170 NPR2 WDR33 KBTBD2 TRIM22 KLRF1 AKAP9 LY75

2.95e-051981598M5591
CoexpressionGSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP

ATP5PB PHACTR2 MYO7A EIF4A3 CEP57L1 SMARCAD1 HEATR6 PRPS1

3.17e-052001598M7043
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TPR USP34 PARP14 SP110 TRIM22 CEP350 KMT2C AKAP9 ATF7IP BOD1L1 ANKRD12 ZNF292

9.26e-122001601212f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

MAP9 PHACTR2 CEP350 CEP170 UBXN4 AKAP9 TAX1BP1 BOD1L1 ANKRD12

4.38e-08198160976d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.

GAD1 PDE1A NXPH1 CEP170 DST AKAP9 SNTG1 BOD1L1 ANKRD12

4.58e-081991609b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

TPR PHACTR2 CEP350 UBXN4 DST AKAP9 BOD1L1 ANKRD12 ZNF292

4.58e-081991609c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GAD1 NXPH1 PTPRO ASPM ADAMTS20 FGF13 UBASH3B NXPH2

4.50e-0719016082f54da2bee411f8868348a4c37034184b8f58a89
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

USP34 MAP9 RO60 CEP350 AKAP9 PTPRK WDFY3 MGA

5.07e-071931608abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GAD1 KMT2C DST AKAP9 BOD1L1 RESP18 KIF5B MGA

5.48e-0719516083e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GAD1 KMT2C DST AKAP9 BOD1L1 RESP18 KIF5B MGA

5.48e-0719516087796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

TTF1 CEP350 AKAP9 ASPM BOD1L1 ANKRD12 NOL8 ZNF292

5.92e-0719716080fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellCOVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters

UIMC1 CNST WDR33 IFNGR1 UBXN4 AKAP9 ANKRD12 ZMYM5

6.15e-0719816083d8c33dba759df0974aeb2b9a6b5167ae7a18e1f
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

TPR CEP350 FHAD1 UBXN4 AKAP9 BOD1L1 ANKRD12 ZNF292

6.39e-071991608fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellLPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HMGCL RYR3 THEM4 ASPM SGO2 AURKB PRPS1

2.20e-0616416074307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCellLPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HMGCL RYR3 THEM4 ASPM SGO2 AURKB PRPS1

2.20e-0616416071d84aa5b925f502ee9c5fa39714490f613a58028
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DAB2IP PHF19 BARD1 KLRF1 ASPM SGO2 AURKB

4.07e-0618016071c1b25f1d22518db5469707131510daae84716a3
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GAD1 PHACTR2 NXPH1 BARD1 PLXNC1 FGF13 KLKB1

4.22e-061811607bd7e9437839bca543ca5945df43d6525e6a312a8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 GLCCI1 TBC1D4 LIPG PKHD1 ARHGAP29 WDFY3

4.22e-061811607071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 TBC1D4 LIPG PKHD1 ARHGAP29 WDFY3 UBASH3B

4.53e-061831607738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PHF19 PECAM1 TBC1D4 ASPM ARHGAP29 SGO2 AURKB

4.53e-06183160752af3c943116073c8ddd207b664342960b88929b
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

PARP14 SP110 TRIM22 CEP350 KMT2C DST ZNF292

4.53e-0618316078f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 TBC1D4 LIPG PKHD1 ARHGAP29 WDFY3 UBASH3B

4.53e-06183160792fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

TPR USP34 PHACTR2 CEP350 BOD1L1 ANKRD12 KIF5B

5.04e-06186160703db813598b67b1e08f759758a1c2023396921fa
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GAD1 NXPH1 PTPRO ASPM FGF13 UBASH3B NXPH2

5.41e-0618816073139540a656c0436b2123ea50741ff8d00112165
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 TBC1D4 LIPG PKHD1 ARHGAP29 WDFY3 UBASH3B

5.60e-061891607904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

TFDP1 FBLN1 CSE1L ASPM SGO2 DNA2 AURKB

5.80e-061901607d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellCOVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters

UIMC1 CNST WDR33 IFNGR1 UBXN4 ANKRD12 ZMYM5

6.43e-06193160798a52523aa1efd5d14a2878ed106828a80a33aa2
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

PARP14 SP110 TRIM22 IFNGR1 TLE5 ANKRD12 ZNF292

6.43e-0619316077256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells)

PHF19 BARD1 ASPM SGO2 KIF4B IL17RB AURKB

6.65e-061941607a12b64945e10f00aa983678a02586c59badc1570
ToppCellCOVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters

UIMC1 CNST WDR33 IFNGR1 UBXN4 ATF7IP ZMYM5

7.11e-061961607ad43efdd4d73b6615f65f06a315b33576e317473
ToppCellCOVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class

PECAM1 PARP14 SP110 TRIM22 LIMD2 TLE5 ANKRD12

7.35e-061971607e666f6580e9a20b5e550f02125706db17eec8510
ToppCellmild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TPR PHACTR2 TRIM22 TAFA2 THEM4 TBC1D4 ANKRD12

7.35e-06197160739800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

PARP14 SP110 TRIM22 KMT2C BOD1L1 ANKRD12 ZNF292

7.35e-0619716075c33454b10023decd2f5ccda9229b6512659711e
ToppCellCOVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters

UIMC1 CNST WDR33 IFNGR1 UBXN4 ATF7IP ZMYM5

7.59e-061981607abfddbee99ef8c7719e6e6f62571e9be030e4acf
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

PARP14 SP110 TRIM22 KMT2C BOD1L1 ANKRD12 ZNF292

7.59e-06198160744417089b62056269cac38d3134ff209c05b7007
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PARP14 SP110 TRIM22 KMT2C BOD1L1 ANKRD12 ZNF292

7.59e-06198160728ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 PARP14 TRIM22 AKAP9 ATF7IP ANKRD12 ZNF292

7.85e-061991607f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

MAP9 CEP350 FHAD1 UBXN4 AKAP9 BOD1L1 ANKRD12

7.85e-06199160761b1ed2db71b96157b92b7535d1955a4033098da
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

PHACTR2 UBXN4 AKAP9 TAX1BP1 BOD1L1 ANKRD12 ZNF292

7.85e-06199160753ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCellCOVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class

PARP14 TRIM22 LIMD2 TLE5 BOD1L1 ANKRD12 ZNF292

8.11e-06200160762c25042086f1afd1102e0720e933c2e476468fd
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type.

GAD1 NXPH1 DST AKAP9 ELAVL3 ANKRD12 NXPH2

8.11e-062001607c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

DAB2IP FSIP1 ADCY9 DNAH1 KLRF1 C5

9.47e-061351606b444005987093efab3265201b3541d7941816cc2
ToppCell356C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NPR2 FSIP1 HDX KLRF1 ELAVL3 KLRB1

1.73e-051501606ecc4fc94958cf2378dd003966dccba81b3c00f8e
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP9 ARRDC5 TRIM31 SMARCAD1 GLCCI1 KLRF1

1.86e-051521606669d8f12fdb110ed72f4e5348b7b5350144a061c
ToppCellPND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CNST FAT3 TFDP1 LIMD2 TBC1D4 IL4

2.23e-0515716068c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804
ToppCellPND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CNST FAT3 TFDP1 LIMD2 TBC1D4 IL4

2.23e-051571606ee1be3c756b72fceac6b4ccb416dd4bd031a2193
ToppCellPND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CNST FAT3 TFDP1 LIMD2 TBC1D4 IL4

2.23e-051571606008f938a338f43c3251dcac574f1b4f689926c71
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYO7A PECAM1 LIMD2 SLC39A12 PLXNC1 SRGAP2B

2.48e-051601606709ce00699ca05346287868ea55a1affae0859a8
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

TBC1D2 HMGCL SMARCAD1 FHAD1 KLRF1 MFN2

3.27e-05168160694cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAT3 CNTN6 RYR3 DNAH1 PKHD1 KLKB1

3.38e-05169160612bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

PHF19 MYO7A FSIP1 CEP57L1 CSE1L SGO2

3.61e-051711606b113fbebb89056af0b9c775d2fb6552206a80467
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

TPR TBC1D4 TLE5 FGF13 ANKRD12 IL17RB

3.73e-0517216069497948bbe53fb88c6ff6b347f743d456da587e5
ToppCell390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CCDC170 IFNGR1 FHAD1 PTPRO AFP WDFY3

3.85e-0517316061f725ff16e28636b20ef26f3fa9be8b47c89378d
ToppCelldroplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO7A NXPE4 PECAM1 GLCCI1 MB21D2 ARHGAP29

3.85e-051731606fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f
ToppCellRSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

TBC1D2 PARP14 SP110 TRIM22 GLCCI1 LIMD2

4.10e-051751606ff3a27f512a3a710ebc863b7b75cce8167d5440b
ToppCellRSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster

TBC1D2 PARP14 SP110 TRIM22 GLCCI1 LIMD2

4.10e-051751606ca52b99b03535a5b3a2751d6981708dc5b255b91
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FSIP1 EIF4A3 BARD1 ASPM SGO2 AURKB

4.10e-05175160686dfce849b2ec023a72f7e887fa681b117155e51
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPR CMYA5 CEP350 FBLN1 TBC1D4 ATF7IP

4.24e-051761606749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 TBC1D4 LIPG PKHD1 WDFY3 UBASH3B

4.24e-051761606327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells)

PHF19 MYO7A CEP57L1 CSE1L ASPM SGO2

4.24e-0517616064bba41ebf9dd187c8705a6997ed039878de62b4e
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PHF19 PECAM1 BARD1 ASPM SGO2 AURKB

4.24e-0517616068385435074cc5235b7af7424974f609388fc2cff
ToppCellfacs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCPH1 MYO7A CEP57L1 ASPM SGO2 AURKB

4.37e-0517716068a0f0fbb06cdacb99a3fdba0da3e0494b891db4f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 GLCCI1 TBC1D4 LIPG PKHD1 ARHGAP29

4.37e-051771606da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCellfacs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCPH1 MYO7A CEP57L1 ASPM SGO2 AURKB

4.37e-051771606e9d7682517fb30fd2ad535d59779d718a7024c13
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP TPR PARP14 AKAP9 TAX1BP1 ARHGAP29

4.51e-05178160601dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PDE1A PHACTR2 MYO7A TRIM22 ASPM ARHGAP29

4.66e-051791606c815eb9f760fe4ca7a5e49beb224659f0b864f22
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PHF19 BARD1 DDIAS ASPM SGO2 AURKB

4.66e-05179160654191c00b29f53b520cd3243b5791daa4a2c72d7
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PDE1A PHACTR2 MYO7A FHAD1 AFP ARHGAP29

4.66e-05179160653e700494d251ec5649b2dea5fc7d5aeeeed572b
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP PHACTR2 PECAM1 PLXNC1 SNTG1 RESP18

4.80e-051801606dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCellLPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PHF19 BARD1 DDIAS ASPM SGO2 AURKB

4.80e-051801606334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP PHACTR2 PECAM1 PLXNC1 SNTG1 RESP18

4.80e-051801606423454e3390080ae03bb3cbb267255ebfe4df080
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PHF19 PECAM1 ASPM ARHGAP29 SGO2 AURKB

4.80e-051801606b35a8c6169f4b548b912af005e92ae7c6596f376
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PDE1A BARD1 TAFA2 PTPRK FSHR ARHGAP29

5.26e-051831606b5d041d0a3506c33de72bf14fa0443f4410fddf1
ToppCellNS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1A CEL FAT3 TBC1D4 DST NXPH2

5.26e-051831606ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

PHF19 BARD1 ASPM SGO2 DNA2 AURKB

5.26e-051831606a48a6313f2f144586951cece97ec31f6d72361df
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PDE1A TRIM22 TAFA2 PTPRK ASPM ARHGAP29

5.26e-051831606c7e94fe3e7669db9304b249979fef7a69c30a143
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BARD1 TFDP1 DDIAS ASPM SGO2 AURKB

5.43e-0518416061edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

TBC1D2 CEP57L1 HMGCL SMARCAD1 KLRF1 MFN2

5.43e-051841606e6bf826be31e1723e24c366fc5a1cee9b15589bc
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GAD1 NXPH1 ASPM FGF13 UBASH3B NXPH2

5.43e-051841606ae0a77e3e520a246b17776bb19503519636b02ee
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BARD1 TFDP1 DDIAS ASPM SGO2 AURKB

5.43e-0518416068578c50eaa8ce1cefc0228185c66c8e25f4bfc32
ToppCellcritical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PDE1A CEL FAT3 TBC1D4 DST NXPH2

5.43e-05184160658d36577eff814d46d72f031f3533d71549e3d6e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 GLCCI1 TBC1D4 LIPG PKHD1 ARHGAP29

5.43e-051841606da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCellControl-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

PHACTR2 CNST GLCCI1 MB21D2 TBC1D4 ZNF292

5.59e-051851606e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCellfacs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FSIP1 BARD1 DDIAS ASPM SGO2 AURKB

5.76e-0518616069feef5936985e936b3d88f9d1bb012abb6468570
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GAD1 NXPH1 ASPM FGF13 UBASH3B NXPH2

5.76e-05186160677592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCellfacs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FSIP1 BARD1 DDIAS ASPM SGO2 AURKB

5.76e-05186160689f5b06bc56674af304912d481ac697c7c870904
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPR UBXN4 AKAP9 TAX1BP1 ANKRD12 KIF5B

5.93e-051871606663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

USP34 PARP14 KMT2C ATF7IP ANKRD12 RAPGEF2

6.11e-051881606ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PHF19 DDIAS KLRF1 ASPM SGO2 AURKB

6.11e-051881606319fbeca200ab998daf49fcaee0bfdb57bf7ee4b
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type

PHF19 BARD1 ASPM SGO2 KIF4B AURKB

6.11e-0518816066c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

GLCCI1 TBC1D4 LIPG PKHD1 ARHGAP29 UBASH3B

6.11e-05188160663a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCellIPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

PHACTR2 CNST GLCCI1 TBC1D4 UBASH3B ZNF292

6.29e-0518916067a260485c2a7c743c14d048e5e480ae0a9b8e32c
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCDC170 DNAH3 CEL FAT3 FHAD1 NXPH2

6.29e-051891606cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCellfacs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM31 BARD1 DDIAS ASPM SGO2 AURKB

6.29e-051891606bfa3ed1360991a3e32fad133017c413f8adc1eba
ToppCellfacs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM31 BARD1 DDIAS ASPM SGO2 AURKB

6.29e-05189160696f10c63656e446b4bb712f012e91ae986f8c2d0
ToppCellEpithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4)

CCDC170 MAP9 DNAH3 FSIP1 FHAD1 CFAP52

6.29e-0518916060bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GAD1 NXPH1 ADAMTS20 FGF13 UBASH3B NXPH2

6.29e-051891606979b7fa947538aa7ca4a219263da2575869a2caa
ToppCellCOVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type

CYP24A1 MYOM3 PKHD1 SLC5A12 NR1H4 IL17RB

6.29e-0518916060be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 KLRF1 ASPM SGO2 KLRB1 AURKB

6.48e-051901606185ae04c68f825cd346aa65072cc5da6a39dff4a
ToppCellcritical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PDE1A CEL FAT3 TBC1D4 DST NXPH2

6.48e-05190160605a2c3549b68f49081723bf35db14974274419d5
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PHACTR2 CNST GLCCI1 TAFA2 TBC1D4 TLE5

6.48e-051901606b69709323a9f1b368b5a4f87295b9f7fd9c9be8e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 KLRF1 ASPM SGO2 KLRB1 AURKB

6.48e-051901606e38dc41f2e79e3bd51326581c6ebe51927edb549
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

GLCCI1 CEP350 KMT2C UBXN4 DST AKAP9 ANKRD12

3.04e-07491007GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
DrugQuinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A

GAD1 TRAF2 WDR33 RO60 BCR UBOX5 CEP350 RRP12 BAIAP3 NR1H4

1.29e-06198158107317_UP
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA

TPR PHACTR2 BARD1 RO60 TTF1 CEP350 UBXN4 KIF5B ZNF292

4.21e-061771589985_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

AMD1 KBTBD2 TTF1 CEP350 ATF7IP ASPM RAPGEF2 MGA ZNF292

5.77e-0618415892321_DN
DrugMethylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; HL60; HT_HG-U133A

TRAF2 MCPH1 RHBDF2 UBOX5 PTPRO GLG1 PACS2 WDFY3 ZNF574

9.61e-0619615893040_DN
DrugSulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A

GAD1 PHACTR2 RHBDF2 ZNF189 BARD1 ADCY9 RRP12 MGA ABCC10

1.04e-0519815891913_DN
DrugSpironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A

GAD1 DNAH3 TRAF2 LHPP RO60 FBLN1 GLG1 C5 WDFY3

1.09e-0519915895781_DN
DrugG-I 4

LHCGR FSHR IL4

1.79e-0581583CID011957434
DrugClorgyline

MAP9 MIPOL1 CEP350 DST AKAP9 BOD1L1 ANKRD12 ZNF292

2.34e-051681588ctd:D003010
Drugtriethylamine

PHF19 TRIM31 SNTG1 PACS2 C5

2.49e-05501585CID000008471
Diseaseuric acid measurement

USP34 GAD1 DNAH3 PDE1A CEL FSIP1 FAT3 CYP24A1 ADCY9 MIPOL1 UBASH3B

3.19e-0461015111EFO_0004761
Diseasearterial stiffness measurement

DAB2IP HMGCL PTPRK ZMYM5

3.30e-04641514EFO_0004517
DiseasePostaxial polydactyly type A

KIAA0825 GLI3

3.85e-0461512C3887487
DiseaseMalignant neoplasm of breast

CYP24A1 BARD1 SP110 CNTN6 LHCGR LIMD2 SLC39A12 ALKBH8 ARFRP1 AKAP9 AFP TAX1BP1 ARHGAP29 BOD1L1 PRPS1

4.24e-04107415115C0006142
Diseaseinterleukin-17 receptor B measurement

MFN2 IL17RB

5.37e-0471512EFO_0801719
Diseasemicrocephaly (implicated_via_orthology)

MCPH1 EXOSC1 ASPM

5.84e-04321513DOID:10907 (implicated_via_orthology)
Diseasemicrocephaly (is_implicated_in)

MCPH1 ASPM

7.14e-0481512DOID:10907 (is_implicated_in)
Diseaselongitudinal alcohol consumption measurement

SPATA31C2 MIPOL1

9.15e-0491512EFO_0007645
Diseaseemphysema imaging measurement

LRRC19 PTPRK ANKRD12 KLKB1 NXPH2

9.50e-041461515EFO_0007626
Diseasehypospadias

PHACTR2 EXOC3 TAX1BP1

1.05e-03391513EFO_0004209
DiseaseMYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)

SP110 IFNGR1

1.14e-03101512C1834752
DiseaseMycobacterium tuberculosis, susceptibility to

SP110 IFNGR1

1.14e-03101512cv:C1834752
DiseaseMYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO

SP110 IFNGR1

1.14e-03101512607948
Diseaseresponse to antihypertensive drug

NXPH1 ZIM3 RAPGEF2

1.21e-03411513EFO_0005405
Diseasegranulosa cell tumor (is_marker_for)

LHCGR FSHR

1.39e-03111512DOID:2999 (is_marker_for)
DiseasePulmonary Thromboembolisms

DAB2IP KLKB1

1.66e-03121512C0524702
DiseasePulmonary Embolism

DAB2IP KLKB1

1.66e-03121512C0034065
DiseasePrecursor B-Cell Lymphoblastic Leukemia-Lymphoma

ATF7IP MGA

1.66e-03121512C0023485
Diseasewaist circumference

SMARCAD1 ADCY9 TBC1D32 ARFRP1 PTPRK PKHD1 SNTG1 RESP18

1.71e-034291518EFO_0004342
DiseaseAdenoid Cystic Carcinoma

CNTN6 KMT2C ASPM MGA

1.77e-031001514C0010606
Diseasemelanoma

MYO7A SLC39A12 PTPRK PTPRO ADAMTS20 KLRB1

1.79e-032481516C0025202
Diseaseresponse to hydrochlorothiazide, triglyceride measurement

DAB2IP IFNGR1 ARHGAP29

1.81e-03471513EFO_0004530, EFO_0005202
Diseasecognitive inhibition measurement

CNST SLC39A12 SNTG1

2.16e-03501513EFO_0007969
DiseaseAutosomal recessive primary microcephaly

MCPH1 ASPM

2.61e-03151512cv:C3711387
Diseaseprimary autosomal recessive microcephaly (is_implicated_in)

MCPH1 ASPM

2.98e-03161512DOID:0070296 (is_implicated_in)
Diseasepartial epilepsy

ADCY9 TBC1D32

3.36e-03171512EFO_0004263
Diseasecoronary artery disease

DAB2IP PDE1A CLTCL1 CEL WDR33 PECAM1 PTPRO LIPG PKHD1 KIF4B C5 RAPGEF2 UBASH3B ABCC10

3.37e-03119415114EFO_0001645
DiseaseColorectal Carcinoma

DNAH3 ZNF560 KMT2C CSE1L AKAP9 GLI3 ETAA1 PKHD1 ZNF292 PRPS1

3.40e-0370215110C0009402
Diseaseneuroimaging measurement

TMCO5A MCPH1 FAT3 NXPH1 SMARCAD1 BCR GLCCI1 SLC39A12 GLI3 FSHR PKHD1 ADAMTS20 RAPGEF2

3.45e-03106915113EFO_0004346
Diseasenon-high density lipoprotein cholesterol measurement

CCDC170 USP34 CEL TRIM31 FBLN1 CSE1L LIPG UBASH3B NR1H4 ZNF574

3.79e-0371315110EFO_0005689
DiseaseProstatic Neoplasms

DAB2IP TBC1D2 SMARCAD1 KMT2C FBLN1 PTPRK MGA NOL8 ZNF292

4.57e-036161519C0033578
DiseaseMalignant neoplasm of prostate

DAB2IP TBC1D2 SMARCAD1 KMT2C FBLN1 PTPRK MGA NOL8 ZNF292

4.57e-036161519C0376358
Diseasehepatocellular carcinoma (is_marker_for)

DAB2IP ATP5PB KLRF1 AFP ASPM NR1H4

4.65e-033011516DOID:684 (is_marker_for)
Diseasegluteofemoral adipose tissue measurement

UBOX5 LHCGR PKHD1 FGF13

4.80e-031321514EFO_0803317

Protein segments in the cluster

PeptideGeneStartEntry
LTRKSQKITNCEQSS

TMCO5A

106

Q8N6Q1
RICDETANATSTLKK

TTF1

71

Q15361
SKNVSGQTDKCREET

CEP170

766

Q5SW79
KKKNTCSFFRRTQIS

ADCK1

476

Q86TW2
ESFRQKQEATESLKC

AKAP9

1881

Q99996
SKEESKQKLVSFCSQ

BARD1

231

Q99728
CERFLKQQQTSIKSS

TBC1D32

1041

Q96NH3
AKCIQVTEVKSSTLN

BAIAP3

256

O94812
IREQQKKCFRSFSLT

BCR

861

P11274
CRKFDTVQASESLKS

ALKBH8

296

Q96BT7
VIFKRNEISKSCNRE

ADAM18

706

Q9Y3Q7
CRADKAKSQQVRTSS

GLCCI1

151

Q86VQ1
TNVKVIRDFTTNKCK

ELAVL3

311

Q14576
KSSNCVVDSRFVLKI

NPR2

646

P20594
EEALQNKKISTSCSV

ANKRD12

431

Q6UB98
KKRCLQATITQDSTY

CEL

81

P19835
TVTKRKATCTRENQT

ASPM

496

Q8IZT6
SISTQQEKETIAKCI

ATP5PB

226

P24539
QTLKYCSVSESQIKE

ADAMTS20

196

P59510
ESVTLEFAKENRKCQ

GORAB

316

Q5T7V8
TLETKESKSFNCRIE

NXPH2

176

O95156
KSCREKTELTPDQQT

NR1H4

251

Q96RI1
KRCKQLESTQTESNK

KIF5B

606

P33176
TLFKCQEETTQKLVL

DAB2IP

1061

Q5VWQ8
QQTICKRFANKTVLT

ABCC10

1421

Q5T3U5
LKSFCTAKETTIRVN

nan

1016

O00370
NTTSKREECLQVKTV

GLI3

681

P10071
ESTKRVEKDIVFCSN

KMT2C

4226

Q8NEZ4
QCAQETKLDFSVVRT

HDX

36

Q7Z353
ISENFSKQCESTVRK

LHCGR

296

P22888
SKQCESTVRKVNNKT

LHCGR

301

P22888
DEKESVSNCIQLKTS

MCTS2

6

A0A3B3IRV3
CEDIVVKSFSESQNK

MAP9

121

Q49MG5
CYITQTRRKKNVTES

MAG

531

P20916
FSCVGKKTRTVDITN

MCPH1

461

Q8NEM0
FARSEVQLKKCISSS

MB21D2

291

Q8IYB1
NRKESCKSFTRLTAQ

KIAA0825

956

Q8IV33
RSKSFSLRAQVKETC

LIMD2

26

Q9BT23
LIKETKTCQENSDVF

MGA

2201

Q8IWI9
CQVTSDSDKEKTIAF

MIPOL1

101

Q8TD10
EFQEVSKESKRQLQC

DST

5066

Q03001
SQQVDEKCSFLETKL

DST

5156

Q03001
VFTTEINNQTSKCIK

ARRDC5

206

A6NEK1
QEFLTVVKCSIAKSQ

KIAA1109

2861

Q2LD37
TITQAVIFCNTKRKV

EIF4A3

276

P38919
ACKKNEETVEVNFTT

IL17RB

186

Q9NRM6
KSSVSCIRVKRNNEE

CFAP52

461

Q8N1V2
AFKERQSSKNLLSCE

GAD1

66

Q99259
VKNVDSSRELCQNKS

PLXNC1

536

O60486
KELAAQEARTSSQKC

PDE1A

516

P54750
NYTCKVESSRISKVS

PECAM1

301

P16284
SSQVIVKANCSKDDF

DDIAS

481

Q8IXT1
SVVTSCKNFKVRIRS

HEATR6

1006

Q6AI08
KTSKLQTAFRTVNCF

KBTBD2

336

Q8IY47
VKSGETQRKLTFCTE

LIPG

451

Q9Y5X9
VSLCQKYSEVKSRQT

LY75

1086

O60449
VTCKVSSINSRFAKV

EXOSC1

71

Q9Y3B2
SRLKVRFCTNESQKS

LHPP

46

Q9H008
LSVNRENAKCFTTKE

PHACTR2

391

O75167
STKKTSFKNRENCEL

NOL8

406

Q76FK4
VTKNTLKCTFRSLQV

PACS2

771

Q86VP3
KDRVFTDKTSATVIC

IL12B

286

P29460
EECISQSAVKTKFEQ

MFN2

346

O95140
TDQKEICTFNSKTVK

ETAA1

411

Q9NY74
ICTFNSKTVKNTSRA

ETAA1

416

Q9NY74
RKDSKTSESICEINN

ETAA1

656

Q9NY74
SVVSLTCQKQKESQR

PTPRO

466

Q16827
VSSVLQECEKKNYSS

PARP14

1311

Q460N5
TLQQEKTDTVRCIKS

FBLN1

566

P23142
ACTNTKKLEETDFVL

OR6S1

191

Q8NH40
VNRKDAATTVCSKFN

ARHGAP29

1056

Q52LW3
CFTSEVVSKALKQEV

RESP18

166

Q5W5W9
QKTSATVQKDELRTC

BOD1L1

1156

Q8NFC6
EEECNLTLNKKSRSS

FRG2C

116

A6NGY1
TALSKVRAECNKVTA

DNAH1

511

Q9P2D7
STRCHQKVFKLQETE

GLG1

856

Q92896
SKQAFEKVVTSEALC

ARFRP1

111

Q13795
TTTSRQNEKEISQKC

FHAD1

271

B1AJZ9
KNTTEKETFCRAATV

IL4

61

P05112
NSCAAIKESKIFSET

KLRF1

206

Q9NZS2
DTIFKSVKACIDNRL

CYP24A1

276

Q07973
TTSNCFKQTIEKVLI

DNAH3

2331

Q8TD57
SEITFIKKVTCTNAE

C5

1596

P01031
TVCDSERLVSSQKKS

CMYA5

1501

Q8N3K9
DVQCSIISVTKTDKQ

AMD1

46

P17707
FSCRETRVAQKLAEK

FAT3

681

Q8TDW7
QCLSSEETKNKVVSF

C1orf112

731

Q9NSG2
KVQKVAQLSSTECRT

CEP350

401

Q5VT06
DLAQTVKTFDNLKTC

ADCY9

616

O60503
TIQAAKDSSVKLECF

CNTN6

236

Q9UQ52
QCAVFDKTLAELKTR

ATF7IP

611

Q6VMQ6
TSCDKNKLNVFSRVK

FGF13

36

Q92913
CLQFSKDVIISDTKD

FSIP1

506

Q8NA03
FTISIEQRKKSDKNC

KIF4B

216

Q2VIQ3
FNVSKVSSVEECQKR

KLKB1

126

P03952
ECFRLTTTQKTAEDK

CEP57L1

181

Q8IYX8
ASEVNREQKKAASCT

CCDC170

236

Q8IYT3
SNRVFLCQESKVTEI

FSHR

26

P23945
NCQTFKESIVSLKRK

EXOC3

496

O60645
QFTEQEICRSKSIKS

DNA2

711

P51530
KQTLDELKCTRFSIS

FAM53C

11

Q9NYF3
TRSTCIKNEKIHQFQ

SLC39A12

261

Q504Y0
IAAVEKSQERKCSTQ

CNST

281

Q6PJW8
KSQERKCSTQLLVSE

CNST

286

Q6PJW8
VTTEKSKEVCITIFN

IFNGR1

226

P15260
CFQTKAATVTKELRE

AFP

201

P02771
KIQSSKREVQCNFTE

LRRC19

21

Q9H756
TKTQCVRIATKAATE

PTPRK

721

Q15262
NKIEERSQTVKCSCF

TAFA2

56

Q8N3H0
GKVIDQSTLEKCNRS

UBOX5

281

O94941
LQASEVQSKRKEATC

TRIM31

81

Q9BZY9
LTTSSKEDTCFLKEQ

TAX1BP1

341

Q86VP1
VTAESQKTVKNRSCV

SPATA31C2

1031

B4DYI2
IKTNSSEGKVFINIC

PIH1D1

56

Q9NWS0
CSNTVQEKTFNKDTV

SMARCAD1

106

Q9H4L7
EKFNTISVSKCNKET

NXPE4

286

Q6UWF7
QTVIDAKDSKSFNCR

NXPH1

181

P58417
VTAESQKTVKNRSCV

SPATA31A6

1181

Q5VVP1
QTATFLEVERIQCKT

SNTG1

386

Q9NSN8
SELFTKKNINCSIEE

HMGCL

131

P35914
VKKISRSCSVNNKVS

FAM120AOS

226

Q5T036
LTCNKSKASRQTFVI

SGO2

526

Q562F6
AERFLAKTCSTKDQQ

SRGAP2B

71

P0DMP2
VATSSSFDCIQDKVK

PKHD1

3206

P08F94
EKDICSSSKRRFQKN

SP110

431

Q9HB58
VTKKFSNQETCVEID

PRPS1L1

31

P21108
QCSDISTKQAAFKAV

RO60

101

P10155
STKQAAFKAVSEVCR

RO60

106

P10155
AISTAKFCIQEIEKS

RRP12

281

Q5JTH9
IKVCNENSLFKSEAR

CLTCL1

931

P53675
LQKSCTFDEQRTATI

AURKB

166

Q96GD4
QQLKFTTSDSCDRIK

TLE5

16

Q08117
KTSCANLKRFEEVIN

RAPGEF2

751

Q9Y4G8
TAESQKTVKNRSCVY

SPATA31A3

1186

Q5VYP0
RCESLEKKTATFENI

TRAF2

271

Q12933
FIIVNTSKKTVIDCS

TFDP1

261

Q14186
EKCDKSFSQQRSLVN

ZNF189

571

O75820
SINKETLTTQKGVEC

ZIM3

106

Q96PE6
EKSQDNVIKVCASVT

CSE1L

51

P55060
YTSKEKTSINLQACE

WDFY3

1646

Q8IZQ1
TAESQKTVKNRSCVY

SPATA31A1

1186

Q5TZJ5
TTQKAESQLLECKAS

TPR

1116

P12270
RKFFVSCNVQSVDEK

THEM4

206

Q5T1C6
SEKFDLNKNCTVTVT

RYR3

1356

Q15413
SECKKLFSTETSLQV

ZNF574

741

Q6ZN55
VFKRCCNSQVKETSE

ZNF292

2426

O60281
KRVSSSKQSCLVTFE

PHF19

61

Q5T6S3
VVLEKNFKDISSCSQ

TBC1D4

376

O60343
NTCRKTFSQKSNLIV

ZNF33A

751

Q06730
TQNTRSIICKKDAST

ZMYM5

281

Q9UJ78
DGVCTKITQKQVSTE

ZNF543

161

Q08ER8
VTKKFSNQETCVEIG

PRPS1

31

P60891
SRSFQVTKEIISECK

UBASH3B

551

Q8TF42
AINCEKFTETLVKLS

USP34

3156

Q70CQ2
VTTKFVRTSTNKVKC

WDR33

106

Q9C0J8
VTAEKSSDKRQSQVC

ZNF589

236

Q86UQ0
NQSTIQRCISCKTEK

SLC5A12

256

Q1EHB4
NECGKAFIQKTTLTV

ZNF382

411

Q96SR6
NSFVAIKIDTKSEAC

UBXN4

51

Q92575
IKIDTKSEACLQFSQ

UBXN4

56

Q92575
TQRKDCSETLATFVK

RHBDF2

511

Q6PJF5
GECKKTFSQQSRLTQ

ZNF425

501

Q6IV72
RQVKTVRTCTFKNSN

TRIM22

321

Q8IYM9
QLRISCKSVDESKVF

ZNF680

121

Q8NEM1
SEATDCLVDFKKQVT

UIMC1

686

Q96RL1
QVICKLSEKVTQDFT

TBC1D2

416

Q9BYX2
QVQRKCTQDKSFEGT

ZNF560

281

Q96MR9
IEKCSVDIQQSRNKT

KLRB1

71

Q12918
STKAKDFCQNIATRL

MYO7A

1921

Q13402
VQLTCKVTNTKKETR

MYOM3

1136

Q5VTT5